Winship investigators will present new cancer research findings at the AACR Annual Meeting, taking place April 8-12.
The 113th annual American Association for Cancer Research (AACR) meeting, to be held in New Orleans April 8-12, will feature numerous oral and poster presentations by Winship Cancer Institute and Emory University investigators and trainees. The conference will have both in-person and virtual components.
On Saturday, Gabe A. Kwong, PhD, Winship member and assistant professor in the Emory University and Georgia Institute of Technology Wallace H. Coulter Department of Biomedical Engineering, will chair a methods workshop from 2:30 to 4 p.m. titled "Synthetic biomarkers: A twenty-first century path to early cancer detection."
On Sunday, Winship member Lauren E. McCullough, PhD, MSPH, assistant professor of epidemiology in the Rollins School of Public Health will discuss "Digging deeper: The biologic manifestation of area-level neighborhood deprivation in breast cancer outcomes" during an Advances in Science of Cancer Health Disparities session from 1:30 to 1:50 p.m., and Winship member Ajay K. Nooka, MD, MPH, will present highlights from the AACR/Harvard Business School/Multiple Myeloma Research Foundation Summit: Reducing Disparities and Democratizing Cancer Care, which was held in October 2021.
Cimona V. Hinton, PhD, Winship coalition member and professor in the Department of Biological Sciences at Clark Atlanta University, will chair a mini-symposium focused on the molecular principles of metastasis, and serve on the "Trust in Science" panel Monday, April 11.
Professor of hematology and oncology in research ethics Rebecca Pentz, PhD, will participate in the "Breaking Down Silos: If We Did It During the COVID Pandemic, Why Not for Cancer?" panel discussion on Tuesday from 5:00 to 6:30 p.m.
Several Emory investigators will give e-poster/poster presentations during the conference in the following categories:
- Adoptive cell therapy – James C. Ackley and Samuel C. McCachren III
- Application of bioinformatics to cancer biology – Jia Yao, PhD
- Biological therapeutic agents – Junghui Koo
- Cancer health disparities – Rebecca Nash and Leah Moubadder
- Cellular and molecular processes of metastasis 1 – Jamie L. Arnst
- Clinical research in special populations – Yufen Lin, PhD, RN
- Combinations – Ganji Purnachandra Nagaraju, MSc, PhD, DSc
- Drug targeting and treatment response of the microenvironment – Justus M. Huelse
- Genetically engineered mouse models – Yijian Fan
- Identification of molecular targets – Sherri K. Smart, MD
- Immune checkpoints – Kelsey B. Bennion
- Immune response to therapies 1 – Svetlana Atasheva
- Innervation, ECM and cell surface receptors – Dailia B. Francis
- Leveraging single cell sequencing technologies and new models to study pediatric malignancies – Garrett Cooper
- Metabolic therapies, detection and technologies – Austin Boese
- Modifiers of the tumor microenvironment – Alisha "Rae" Hunter
- Novel targets and pathways – Eric J. Miller, PhD
- Nutrients, diet and metabolic requirements of cancer – Yong Teng, PhD
- Phase 1 clinical trials – Sagar Lonial, MD, FACP and Eun-Ok Im, PhD, MPH, RN, CNS, FAAN
- Population sciences – Eun-Ok Im, PhD, MPH, RN, CNS, FAAN, and Haley J. Yao
- Preclinical immunotherapy – Andre J. Burnham
- Preclinical prevention, early detection and interception – Jinbing Bai, PhD, RN, FAAN
- Translational research: molecular and clinical session – Batoul Farran
- Tyrosine kinase and phosphatase inhibitors – Aashis Thapa
- Vaccines / immunomodulatory agents and interventions – Lily Yang, MD, PhD
AACR announced that clinical trial and late-breaking abstracts will be posted to the conference planner at 1:00 PM ET on April 8.